Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | Yes |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | Yes | Yes |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Novartis AG |
| 4Front Ventures Corp. |
| Harmony Biosciences Holdings, Inc. |
| Evolus, Inc. |
| Tarsus Pharmaceuticals, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| NVSE.F | FFNT.F | HRMY | EOLS | TARS | SNOA | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 26% | 71% | 26% | 665% | -55% | -65% | ||
| Fiscal Year - 1 | 16% | -65% | 30% | NM | -70% | -62% | ||
| Fiscal Year - 2 | 10% | -96% | 62% | -148% | -35% | -72% | ||
| Fiscal Year - 3 | 37% | -103% | 24% | -1050% | -8% | -84% | ||
| Fiscal Year - 4 | 14% | -287% | 39% | -5017% | NA | -44% | ||
| Fiscal Year - 5 | 11% | -35% | 56% | -110% | NA | -91% | ||
| Average | 19% | -86% | 39% | -1132% | -42% | -70% | ||
| Median | 15% | -81% | 34% | -148% | -45% | -69% | ||
| Benchmarks | Ticker | |||||||
| Novartis AG | PINC:NVSE.F | |||||||
| 4Front Ventures Corp. | PINC:FFNT.F | |||||||
| Harmony Biosciences Holdings, Inc. | NasdaqGM:HRMY | |||||||
| Evolus, Inc. | NasdaqGM:EOLS | |||||||
| Tarsus Pharmaceuticals, Inc. | NasdaqGS:TARS | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | NVSE.F | FFNT.F | HRMY | EOLS | TARS | SNOA | ||
| Latest Fiscal Year | Dec-24 | Dec-23 | Dec-24 | Dec-24 | Dec-24 | Mar-24 | ||
| LTM Period | Dec-24 | Sep-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 51,722 | 76 | 715 | 266 | 183 | 14 | ||
| Fiscal Year | 51,722 | 97 | 715 | 266 | 183 | 13 | ||
| Fiscal Year - 1 | 46,660 | 108 | 582 | 202 | 17 | 13 | ||
| Fiscal Year - 2 | 43,461 | 105 | 438 | 149 | 26 | 13 | ||
| Fiscal Year - 3 | 43,974 | 58 | 305 | 100 | 57 | 19 | ||
| Fiscal Year - 4 | 49,898 | 19 | 160 | 57 | NA | 18 | ||
| Fiscal Year - 5 | 48,677 | 4 | 6 | 35 | NA | 19 | ||
| Net Income | ||||||||
| Latest Twelve Months | 11,941 | (35) | 145 | (50) | (116) | (4) | ||
| Fiscal Year | 11,941 | (45) | 145 | (50) | (116) | (5) | ||
| Fiscal Year - 1 | 8,568 | (21) | 129 | (62) | (136) | (5) | ||
| Fiscal Year - 2 | 6,049 | (38) | 181 | (74) | (62) | (5) | ||
| Fiscal Year - 3 | 22,908 | (60) | 35 | (47) | (14) | (5) | ||
| Fiscal Year - 4 | 8,072 | (179) | (64) | (163) | (27) | (4) | ||
| Fiscal Year - 5 | 7,142 | (9) | (187) | (90) | (5) | (12) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 99,945 | 269 | 811 | 189 | 265 | 15 | ||
| Latest Fiscal Quarter | 102,246 | 278 | 999 | 233 | 377 | 14 | ||
| Fiscal Year | 102,246 | 264 | 999 | 233 | 377 | 15 | ||
| Fiscal Year - 1 | 99,945 | 345 | 811 | 189 | 265 | 16 | ||
| Fiscal Year - 2 | 117,453 | 256 | 674 | 178 | 228 | 19 | ||
| Fiscal Year - 3 | 131,795 | 205 | 433 | 257 | 179 | 15 | ||
| Fiscal Year - 4 | 127,778 | 203 | 427 | 209 | 172 | 15 | ||
| Fiscal Year - 5 | 118,370 | 60 | 107 | 240 | 58 | 14 | ||
| Fiscal Year - 6 | 145,563 | 14 | 89 | 172 | 2 | 19 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 46,667 | (51) | 467 | (21) | 197 | 7 | ||
| Latest Fiscal Quarter | 44,046 | (49) | 659 | 6 | 225 | 5 | ||
| Fiscal Year | 44,046 | (52) | 659 | 6 | 225 | 6 | ||
| Fiscal Year - 1 | 46,667 | 28 | 467 | (21) | 197 | 8 | ||
| Fiscal Year - 2 | 59,342 | 37 | 403 | 18 | 193 | 9 | ||
| Fiscal Year - 3 | 67,655 | 42 | 187 | 82 | 167 | 5 | ||
| Fiscal Year - 4 | 56,598 | 75 | 97 | (73) | 166 | 6 | ||
| Fiscal Year - 5 | 55,474 | 50 | (423) | 79 | (6) | 10 | ||
| Fiscal Year - 6 | 78,614 | (0) | (243) | 84 | (1) | 15 | ||